Valsartan/Hydrochlorothiazide Tablets

PresolicitationActive

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
SPE2D2-25-R-0014
Opportunity Type
Presolicitation
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Wednesday, April 16, 2025
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Valsartan/Hydrochlorothiazide Tablets. Procurement details follow. Valsartan 160 MG-Hydrochlorothiazide 12.5 MG Tablets, Valsartan 160 MG-Hydrochlorothiazide 25 MG Tablets, Valsartan 320 MG-Hydrochlorothiazide 12.5 MG Tablets, Valsartan 320 MG-Hydrochlorothiazide 25 MG Tablets, and Valsartan 80 MG-Hydrochlorothiazide 12.5 MG Tablets in 90 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items lis

Why This Opportunity Matters

The Department of DEFENSE is actively seeking qualified contractors for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.